Literature DB >> 11344871

Syringe prescription to prevent HIV infection in Rhode Island: a case study.

J D Rich1, G E Macalino, M McKenzie, L E Taylor, S Burris.   

Abstract

Injection drug users (IDUs) are a population at high risk for many diseases, including AIDS, and are clearly in need of medical and substance abuse treatment. Access to sterile syringes is critical for lowering the risk of transmission of HIV and other blood-borne pathogens among IDUs. Previously tried strategies include needle exchange programs and changing laws to allow the legal purchase and possession of syringes. An alternative strategy is to have physicians prescribe syringes to IDUs. To the best of our knowledge, this has previously been tried by only a few physicians in rare situations and never on a programmatic basis. This report describes the genesis of physician's syringe prescription in Rhode Island and some of the lessons learned to date. Because of the illicit nature of drug use, a tremendous amount of mistrust and fear on the part of IDUs often leads to poor interaction with the medical establishment. Prescription of syringes by a physician can serve as a tool for reaching out to a high-risk and often out-of-treatment population of drug users. It is a way for the health care community to tap into drug-using networks and bring those populations into a medical care system.

Entities:  

Mesh:

Year:  2001        PMID: 11344871      PMCID: PMC1446672          DOI: 10.2105/ajph.91.5.699

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  1 in total

1.  Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.

Authors:  S Burris; P Lurie; D Abrahamson; J D Rich
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

  1 in total
  9 in total

Review 1.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

2.  Written in response to Scott LD: treating hepatitis C in active injection drug users.

Authors:  Brian R Edlin; Michael R Carden
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

Review 3.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Managing Hepatitis C in Users of Illicit Drugs.

Authors:  Brian R Edlin; Michael R Carden; Stephen J Ferrando
Journal:  Curr Hepat Rep       Date:  2007

5.  A syringe prescription program to prevent infectious disease and improve health of injection drug users.

Authors:  Josiah D Rich; Michelle McKenzie; Grace E Macalino; Lynn E Taylor; Stephanie Sanford-Colby; Francis Wolf; Susan McNamara; Meenakshi Mehrotra; Michael D Stein
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

6.  A success story: HIV prevention for injection drug users in Rhode Island.

Authors:  Curt G Beckwith; Carla C Moreira; Hesham M Aboshady; Nickolas Zaller; Josiah D Rich; Timothy P Flanigan
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-12-04

7.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08

8.  Syringe access for the prevention of blood borne infections among injection drug users.

Authors:  Sharon Stancliff; Bruce Agins; Josiah D Rich; Scott Burris
Journal:  BMC Public Health       Date:  2003-11-21       Impact factor: 3.295

9.  Harm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives.

Authors:  Suzanne Carlberg-Racich
Journal:  PeerJ       Date:  2016-04-14       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.